Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 18 Jul 2025

To explore the potential of LOXL2 as a biomarker in glioma and construct a genomic integrated clinical prognostic model

in Molecular and Cellular Oncology

Hongjuan Wang
Qunli Li
Xiangtao Zheng
Weibiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1602475

1,834 views

Editorial

Published on 17 Jul 2025

Editorial: The cellular and molecular basis of nutrition and lifestyle in cancer prevention and progression

in Molecular and Cellular Oncology

Adin Aggarwal
Maicon Roberto Kviecinski
Fabiana Ourique
Kenneth W. Yip

Frontiers in Oncology

doi 10.3389/fonc.2025.1652368

1,377 views

Review

Published on 17 Jul 2025

“Molecular pigeon” network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer

in Molecular and Cellular Oncology

Mingxiao Li
Ling Dai
Simin Chen
Minjie Deng
Lihuai Wang
Yinhui Sun

Frontiers in Oncology

doi 10.3389/fonc.2025.1578927

2,660 views
2 citations

Original Research

Published on 16 Jul 2025

A study on the clinical value of prophylactic contralateral central lymph node dissection in patients with cT1-T2N1b unilateral papillary thyroid cancer

in Molecular and Cellular Oncology

Suqiong Lin
Rongliang Qiu
Yujuan Tang
Xiaoquan Hong
Qiangbin Ding
Ke Li
Ende Lin
Penghao Kuang
Jinbo Fu
Guoyang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1629656

1,684 views

Methods

Published on 16 Jul 2025

Machine learning-based single-sample molecular classifier for cancer grading

in Molecular and Cellular Oncology

Zoia Antysheva
Nikita Kotlov
Mariia V. Guryleva
Ivan Valiev
Viktor Svekolkin
Anna Belozerova
Sheila T. Yong
Dmitry Tabakov
Alexander Bagaev
Vladimir Kushnarev

Frontiers in Oncology

doi 10.3389/fonc.2025.1617898

2,724 views

Correction

Published on 07 Jul 2025

Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway

in Molecular and Cellular Oncology

Liujing Qu
Yu Xin
Jieni Feng
Xiaolei Ren
Zuming Li
Xueru Chen
Guangyan Miao
Jiankun Chen
Chengming Sun
Yue Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1643772

1,134 views

Original Research

Published on 07 Jul 2025

Functions and mechanisms of UC-MSC-derived exosomal miR-486-5p in pulmonary fibrosis

in Molecular and Cellular Oncology

Xue-feng Shi
Ya-jun Tuo
Zhen-yun Liao
Jie Duo
Hao Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1542008

2,979 views

Review

Published on 04 Jul 2025

Tight junctional protein family, Claudins in cancer and cancer metastasis

in Molecular and Cellular Oncology

Wenxiao Ji
Xinguo Zhuang
Wen G. Jiang
Tracey A. Martin

Frontiers in Oncology

doi 10.3389/fonc.2025.1596460

4,789 views
6 citations

Systematic Review

Published on 02 Jul 2025

Lactylation and its roles in diseases: a systematic bibliometric exploration of the research landscape

in Molecular and Cellular Oncology

Mengjia Li
Yuhang Liu
Chuhan Jiang
Shiyu Zhang
Mengyu Nan
Jiaxi Liu
Yangyang Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1569651

5,506 views
1 citation

Review

Published on 01 Jul 2025

Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance

in Molecular and Cellular Oncology

Minhan Jin
Yuhui Wang
Mingze Song
Wenfei Guo
Shirong Li
Zeqing Pu

Frontiers in Oncology

doi 10.3389/fonc.2025.1566598

4,599 views
2 citations

Systematic Review

Published on 01 Jul 2025

Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies

in Molecular and Cellular Oncology

Huyen Thuc Tran Luong
Sofie Vercammen
Ario de Marco
Hilde de Rooster
Antonio Cosma

Frontiers in Oncology

doi 10.3389/fonc.2025.1623327

4,702 views
4 citations

Systematic Review

Published on 30 Jun 2025

Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025

in Molecular and Cellular Oncology

Tingting Yang
Heng Li
Wenxuan Zhou
Ning Zhang
Zhenyu Tian
Heming Wang
Yuyan Feng
Yunguang Chen
Zhen Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1601261

2,246 views
1 citation

Original Research

Published on 30 Jun 2025

Prevalence of human papillomavirus genotypes in Latvia among women participating in cervical cancer screening

in Molecular and Cellular Oncology

Anna Stasulane
Justine Grundmane
Kristiana Sulte
Janis Stasulans
Solvita Cernavska
Laura Smite

Frontiers in Oncology

doi 10.3389/fonc.2025.1584677

1,949 views
1 citation

Review

Published on 26 Jun 2025

Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer

in Molecular and Cellular Oncology

Taniya Saha
Kiven Erique Lukong

Frontiers in Oncology

doi 10.3389/fonc.2025.1513225

5,823 views
5 citations

Review

Published on 26 Jun 2025

The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies

in Molecular and Cellular Oncology

Wiktoria Strasenburg
Jędrzej Borowczak
Daria Piątkowska
Jakub Jóźwicki
Dariusz Grzanka

Frontiers in Oncology

doi 10.3389/fonc.2025.1567242

2,365 views
1 citation

Review

Published on 25 Jun 2025

Vaccine therapies for glioma: clinical frontiers and potential breakthrough

in Molecular and Cellular Oncology

Ying Xing
Caixia Liu
Yunfeng Feng
Shangyu Li
Yuping Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1613332

3,186 views
1 citation

Original Research

Published on 25 Jun 2025

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants

in Molecular and Cellular Oncology

Chenye Tang
Xiao Guo
Qian Zou
Xinghao Wang
Jian Sheng
Dan Shen
Chun Sun
Shuo Li
Ruilin Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1604169

1,980 views

Original Research

Published on 25 Jun 2025

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway

in Molecular and Cellular Oncology

Jinhai Li
Huawei Zhai
Fujing Cai
Xian Zhang
Yu Zhou
Shuqun Li
Huachun Song
Haifeng Zhang
Guangzheng Sun
Minghui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592616

1,686 views
1 citation

Original Research

Published on 24 Jun 2025

p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation

in Molecular and Cellular Oncology

Xiao Liu
Honglin Qu
Jingmin Li
Xuhong Sun
Zhenlin Wang
Dong Wang
Xianyong Bai
Xiaoyan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1584811

4,418 views
3 citations

Original Research

Published on 24 Jun 2025

CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model

in Molecular and Cellular Oncology

Wei Ning
Yan-Ru Yang
Chen-Xu Wu
Yue Hou
Zhi-Wei Liu
Chang-Bin Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564826

2,614 views

Original Research

Published on 23 Jun 2025

CD16 and Siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells

in Molecular and Cellular Oncology

Chris D. St. Laurent
Zeinab Jame-Chenarboo
Alyssa E. Beck
Stacey Stubblefield
Shiteng Duan
Darren Sigal
Matthew S. Macauley

Frontiers in Oncology

doi 10.3389/fonc.2025.1570121

2,457 views
2 citations

Original Research

Published on 23 Jun 2025

PP1γ promotes esophageal squamous cell carcinoma progression through the PP1γ/YAP1/SOX2 axis

in Molecular and Cellular Oncology

Juan Du
Li Liu
Shutao Zheng
Chenglu Dai
Jingyu Liu
Wei Zhang
Hongwei Pu
Jing Xue

Frontiers in Oncology

doi 10.3389/fonc.2025.1586679

1,677 views
1 citation

Original Research

Published on 23 Jun 2025

Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p

in Molecular and Cellular Oncology

Qi Liu
Yong-Kui Yu
Hao-Miao Li
Wei Wang
Jing Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1542742

1,627 views

Original Research

Published on 20 Jun 2025

MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma

in Molecular and Cellular Oncology

Mst Nasrin Akhtar
Annabell Walter
Kathrin Katenkamp
Yuan Chen
Thomas Lehmann
Wolfram Weschenfelder
Christian Spiegel
Matthias Vogt
Gunther O. Hofmann
Andreas Hochhaus

Frontiers in Oncology

doi 10.3389/fonc.2025.1577859

1,843 views

3,143 articles

articles

To explore the potential of LOXL2 as a biomarker in glioma and construct a genomic integrated clinical prognostic model

Editorial: The cellular and molecular basis of nutrition and lifestyle in cancer prevention and progression

“Molecular pigeon” network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer

A study on the clinical value of prophylactic contralateral central lymph node dissection in patients with cT1-T2N1b unilateral papillary thyroid cancer

Machine learning-based single-sample molecular classifier for cancer grading

Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway

Functions and mechanisms of UC-MSC-derived exosomal miR-486-5p in pulmonary fibrosis

Tight junctional protein family, Claudins in cancer and cancer metastasis

Lactylation and its roles in diseases: a systematic bibliometric exploration of the research landscape

Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance

Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies

Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025

Prevalence of human papillomavirus genotypes in Latvia among women participating in cervical cancer screening

Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer

The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies

Vaccine therapies for glioma: clinical frontiers and potential breakthrough

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway

p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation

CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model

CD16 and Siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells

PP1γ promotes esophageal squamous cell carcinoma progression through the PP1γ/YAP1/SOX2 axis

Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p

MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma